News
- 2024.12.12 EPS Group Presented as 9th International Conference on Vaccines Research & Development
- 2024.08.09 EPS Group Notice on Reorganization
- 2024.05.09 News EPS Holdings, Suzuken Group, and Bushu Pharmaceuticals Sign Partnership Agreement to Support the Introduction of Unapproved Drugs (Drug Loss Products) into the Japanese Market
-
2024.04.23
News
IRO Business Providing Total Business Solutions Starts on Full Scale
-Elimination of drug lag and drug loss, and support for foreign biotech companies entering the Japanese market- - 2024.03.21 EPS Group EPNextS Group will collaborate with Frontage Laboratories, Inc. for Early Phase Clinical Trial and Clinical Site Management in the United States to Improve “Drug Lag” and “Drug Loss” Issues in Japan.
-
2023.09.04
IR
EPS Group Overview of Results for the 32nd Fiscal Year Ended September 30, 2022
- 2023.07.06 EPS Group EPS Supported Important Japan-led International Investigator-Initiated HR+/HER2- Breast Cancer Study in Asia Pacific
- 2023.06.28 IR Notice regarding acquisition of R&E Corporate Ltd (HK) and Taiga Supply Chain Management (Shenzhen) Co., Ltd. by EPS Creative Health Technology Group Limited
- 2023.04.27 News Notice of EPS Group exhibiting at DIA2023 Global Annual Meeting and information about the promotional codes
- 2023.04.13 News EPS Group supports Citeline Pharma Intelligence Awards Japan 2023 as a sponsor!
- 2023.03.10 IR Notice Regarding Capital Alliance Between EPS Holdings, Inc. and Logos Science Co., Ltd. as Strategic Partners
- 2023.03.01 IR Notice Regarding Investment of EPS Corporation in Helte Co., Ltd.
- 2023.02.13 IR EPS Corporation signs agreement with Japan’s MHLW to develop operating environment and conduct surveys to promote Personal Health Records (PHRs)
-
2022.08.26
IR
Establishment of Intermediate Holding Company and Corporate Restructuring
-
2022.07.04
IR
EP-SOGO and EPS International Announce Reorganization of SMO Taiwan
-
2022.07.04
IR
EPS Group Forms Strategic Reorganization for CRO Business
- 2022.06.02 News EPS Holdings will be exhibiting at the DIA2022 Global Annual Meeting held in Chicago.
-
2022.05.09
EPS Group
Launch of a Consolidated Call Center Service Promoting DCT
- 2022.04.28 IR EPS International Announces Changes in Major Shareholders of EPS Korea
-
2022.04.25
EPS Group
Web Seminar Held to Consider Decentralized Clinical Trials (DCT) from the CRC Perspective